P3 Health Partners (PIII) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on P3 Health Partners (PIII) is Moderate Underperform.

The composite score behind that read is -0.30, weighing +0.19 of bullish evidence against -0.36 bearish.

P3 Health Partners last closed at $6.17, -2.99% on the session.

Against the IVW growth benchmark the position is -3.91% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

16 graded predictions for PIII so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks P3 Health Partners in the 96th percentile on return on equity, where 100 is best.

P3 Health Partners is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $46.18M.

StockMap tracks P3 Health Partners as the 66th largest of the 72 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 48 Neutral, 23 Moderate Underperform and 1 Moderate Outperform.

On that composite P3 Health Partners ranks 66th of 72 in the group, against a group median of -0.13.